Amgen has grown revenue 13% a year over three years and 8.4% a year over five, with earnings per share compounding at 2.8%. Revenue growth, 3-year annual rate: +13% (Drug Manufacturers - General median +6.3%). Revenue growth, 5-year rate: +8.4%, growth has picked up over the last three years. Earnings per share, 3-year rate: +2.8%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 19, FY2007 to FY2025, as filed.

AMGNAmgen

HealthcareUSD

$440.34

$265.4052 weeks$443.80

Is it growing?

Is AMGN growing?

Amgen has grown revenue 13% a year over three years and 8.4% a year over five, with earnings per share compounding at 2.8%.

+13%

Revenue growth, 3-year annual rate · Drug Manufacturers - General median +6.3% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +8.4%
Revenue growth, 5-year rate · +13% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +2.8%
Earnings per share, 3-year rate · revenue +13% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed